A developmental toxicity-screening test of valerian

Journal of Ethnopharmacology

Volumn 113, Issue 2, 2007, Pages 204-209

  Yao, Mei ^a   Ritchie, Helen E ^a   Brown Woodman, Patricia D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Developmental toxicity; Pregnancy; Teratology; Valerian

Indexed keywords

EPOXIDE; VALERIAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SAFETY; EMBRYO; EMBRYO CULTURE; EMBRYOTOXICITY; FEMALE; FEMALE FERTILITY; FETOTOXICITY; FETUS; FETUS DEVELOPMENT; FETUS MALFORMATION; GESTATIONAL AGE; NONHUMAN; OVARY; PH; PLACENTA; RAT; RECOMMENDED DRUG DOSE; REPRODUCTIVE TOXICITY; TOXICITY TESTING;

ADMINISTRATION, ORAL; ANIMALS; EMBRYO CULTURE TECHNIQUES; EMBRYONIC DEVELOPMENT; ETHANOL; FEMALE; FETAL DEVELOPMENT; FETAL WEIGHT; FETUS; HUMANS; METACARPAL BONES; PLACENTA; PLANT EXTRACTS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RIBS; STERNUM; TOXICITY TESTS; VALERIAN;

RATTUS; VALERIANA;

EID: 34547743764     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.05.028     Document Type: Article

References (28)

1. Abel E., and Dintcheff B. Effects of prenatal alcohol exposure on growth and development in rats. Journal of Pharmacology and Experimental Therapeutics 207 (1978) 916-921
2. Austin J.A. Why patiemts use alternative medicine. Results of a national study. The Journal of the American Medical Association 279 (1998) 1548-1553
3. Barrow M.V., and Taylor W.J. A rapid method for detecting malformations in rat fetuses. Journal of Morphology 127 (1969) 291-305
4. Bounthanh C., Bergmann C., Beck J.P., Haag-Berrurier M., and Anton R. Valepotriates, a new class of cytotoxic and antitumor agents. Planta Medica 41 (1981) 21-28
5. Bounthanh C., Richert L., Beck J.P., Haag-Berrurier M., and Anton R. The action of valepotriates on the synthesis of DNA and proteins of cultured hepatoma cells. Planta Medica 49 (1983) 138-142
6. Brown N., and Fabro S. Quantitation of rat embryonic development in vitro: a morphological scoring system. Teratology 24 (1981) 65-78
7. Carol A.N., and Linda A.A. Herbal Medicines-A Guide for Health-Care Professionals (1996), The pharmaceutical Press, London
8. Chan T.Y., Tang C.H., and Critchley J.A. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian). Postgraduate Medical Journal 71 (1995) 227-228
9. Donath F., Quispe S., Diefenbach K., Maurer A., Fietze I., and Roots I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33 (2000) 47-53
10. Hobbs C. Valerian. Herbal Gram 21 (1989) 19-34
11. Holz J., and Godot P. Receptor binding studies with valeriana officinalis on the benzodiazepine receptor. Planta Medica 65 (1989) 642
12. Houghton P.J. The biological activity of valerian and related plants. Journal of Ethnopharmacology 22 (1988) 121-142
13. Houghton P.J. Valerian, The Genus Valeriana (1997), Harwood Academic Publishers, London
14. Hui-lian W., Dong-fang Z., Zhao-feng L., Yang L., Qian-rong L., and Yu-zhen W. In vitro study on the genotoxicity of dichloromethane extracts of valerian (DEV) in human endothelial ECV304 cells and the effect of vitamins E and C in attenuating the DEV-induced DNA damages. Toxicology and Applied Pharmacology 188 (2003) 36-41
15. Maats F.H., and Crowther C.A. Patterns of vitamin, mineral and herbal supplement use prior to and during pregnancy. The Australian and New Zealand Journal of Obstetrics and Gynaecology 42 (2002) 494-496
16. MacLennan A.H., Wilson D.H., and Taylor A.W. Prevalence and cost of alternative medicine in Australia. The Lancet 347 (1996) 569-573
17. Mennini T., Bernasconi P., Bombardelli E., and Morazzoni P. In vitro study on the interaction of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine and barbiturate receptors in rat brain. Fitoterapia 64 (1993) 291-300
18. Miyasaka L.S., Atallah A.N., and Soares B.G. Valerian for anxiety disorders. Cochrane Database of Systematic Reviews 4 (2006) CD004515
19. New D.A. Studies on mammalian fetuses in vitro during the period of organogenesis. In: Austin C.R. (Ed). The Mammalian Fetus In Vitro (1973), Chapman and Hall, London 15-65
20. Ortiz J.G., Nieves-Natal J., and Chavez P. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. Neurochemical Research 24 (1999) 1373-1378
21. Perry L. Medicinal Plants of East and Southeast Asia (1994), MIT Press, Cambridge, MA
22. Schulz H.T. Rational Phytotherapy, A physicians-guide to herbal medicine (2002), Springer
23. Shohet D., Wills R.B., and Stuart D.L. Valepotriates and valerenic acids in commercial preparations of valerian available in Australia. Pharmazie 56 (2001) 860-863
24. Taylor P. Practical Teratology (1986), Academic Press, NY
25. Tortarolo M. In vitro effects of epoxide-bearing valepotriates on mouse early hematopoietic progenitor cells and human T-lymphocytes. Archives of Toxicology 51 (1982) 37-42
26. Tufik S., Fujita K., Seabra Mde L., and Lobo L.L. Effects of a prolonged administration of valepotriates in rats on the mothers and their offspring. Journal of Ethnopharmacology 41 (1994) 39-44
27. von der Hude W., Scheutwinkel-Reich M., and Braun R. Bacterial mutagenicity of the tranquilizing constituents of Valerianaceae roots. Mutational Research 169 (1986) 23-27
28. Wagner H., Jurcic K., and Schaette R. Comparative studies on the sedative action of valeriana extracts, valepotriates and their degradation products (author's transl). Planta Medica 39 (1980) 358-365